Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2013-04-30
2014-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Smoking on Activated Clotting Time Values During Coronarography and Angioplasty
NCT04897997
Safety and Feasibility of Transulnar Artery Approach for Coronary Angiography or Angioplasty
NCT01979627
Objective Randomised Blinded Investigation With Optimal Medical Therapy of Angioplasty in Stable Angina
NCT02062593
"SIMULATION MODELING OF CORONARY ARTERY DISEASE: A TOOL FOR CLINICAL DECISION SUPPORT"
NCT04448691
Iliac Angioplasties: Impact of the Fusion of Images on the Irradiation Rate
NCT05353309
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Current Smoker underwent TCA
subjects who smokes daily
smoke expose
Former Smokers underwent TCA
subjects who do not smoke since 7 years
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
smoke expose
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Klinik für Kardiologie, Pneumologie und Angiologie
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Klinik für Kardiologie, Pneumologie und Angiologie
Division of Cardiology, Pulmonary Diseases, Vascular Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christian Heiss, MD
Role: PRINCIPAL_INVESTIGATOR
Division of Cardiology, Pulmonology and Vascular Medicine
Malte Kelm, MD
Role: STUDY_CHAIR
Division of Cardiology, Pulmonology and Vascular Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Division of Cardiology, Pulmonology and Vascular Medicine Duesseldorf,
Düsseldorf, North Rhine-Westphalia, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TCA INJURY
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.